Profilo
A. Stewart Campbell currently works at Axial Therapeutics, Inc., as Chief Executive Officer & Director from 2021 and Synglyco, Inc., as Vice President-Research & Development from 2006.
Dr. Campbell also formerly worked at Insmed, Inc., as Director-Technical Operations, Surface Logix LLC, as Vice President-PreClinical Development, and Boehringer Ingelheim Corp., as Medicinal Chemist.
Dr. Campbell received his doctorate degree in 1992 from Queen's University and undergraduate degree in 1988 from St. Francis Xavier University.
Posizioni attive di A. Stewart Campbell
| Società | Posizione | Inizio |
|---|---|---|
Synglyco, Inc.
Synglyco, Inc. Pharmaceuticals: MajorHealth Technology Develops novel vaccines using synthetic carbohydrates | Direttore Tecnico/Scientifico/R&S | 01/11/2006 |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotherapeutics | Amministratore Delegato | 08/03/2021 |
Precedenti posizioni note di A. Stewart Campbell
| Società | Posizione | Fine |
|---|---|---|
| INSMED INCORPORATED | Direttore Tecnico/Scientifico/R&S | - |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products | Corporate Officer/Principal | - |
Surface Logix LLC
Surface Logix LLC Pharmaceuticals: MajorHealth Technology Manufactures molecular drugs | Corporate Officer/Principal | - |
Formazione di A. Stewart Campbell
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Insmed, Inc.
Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
Surface Logix LLC
Surface Logix LLC Pharmaceuticals: MajorHealth Technology Manufactures molecular drugs | Health Technology |
Synglyco, Inc.
Synglyco, Inc. Pharmaceuticals: MajorHealth Technology Develops novel vaccines using synthetic carbohydrates | Health Technology |
Queen's University
Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Francis Xavier University
St. Francis Xavier University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products | Health Technology |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotherapeutics | Health Technology |
















